We present 3 cases of immunocompetent infants with CMV infection who showed
prolonged liver dysfunction. In all cases the CMV genome was detectable in
hepatocytes using the in situ hybridization method. Combination therapy wi
th ganciclovir (GCV) and hyperimmune gammaglobulin (HGG) was instituted in
2 cases and successfully suppressed the replication of CMV, with sustained
improvement in liver function. In 1 of these cases, signals for CMV DNA wer
e undetectable in the liver 12 months after termination of combination ther
apy. These results help to confirm the etiology of CMV for persistent hepat
itis in immunocompetent infants using the in situ hybridization method and
also show the efficacy of combination therapy with a virostatic agent, GCV,
and an immune-modulating agent, HGG.